mTOR in podocyte function: Is rapamycin good for diabetic nephropathy?

Comment on: Inoki K, et al. J Clin Invest 2011; 121:2181-2196 and Gödel M, et al. J Clin Invest 2011; 121:2197-2209

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell cycle (Georgetown, Tex.) Tex.), 2011-10, Vol.10 (20), p.3415-3416
Hauptverfasser: Lu, Min-Kan, Gong, Xing-Guo, Guan, Kun-Liang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3416
container_issue 20
container_start_page 3415
container_title Cell cycle (Georgetown, Tex.)
container_volume 10
creator Lu, Min-Kan
Gong, Xing-Guo
Guan, Kun-Liang
description Comment on: Inoki K, et al. J Clin Invest 2011; 121:2181-2196 and Gödel M, et al. J Clin Invest 2011; 121:2197-2209
doi_str_mv 10.4161/cc.10.20.17686
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_903148459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>903148459</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-c56fb6b071aad03013e9eba9dc98a363abe569b85865414ca180496ffa85d5ac3</originalsourceid><addsrcrecordid>eNqFkM2LFDEQxYMo7udV2IvMzVOPlc5HJxdBBl2FgQVZzyFdnaxZupPZpFuZ_94ee3dwD-KpHtSvXj0eIW8orDmV9D3iepY1rGkjlXxBTqkQtOIA4uVBM1VxCvSEnJVyD1CrRtPX5KSuQTYNhVNyNdzefFuFuNqlLuF-dCs_RRxDihfklbd9cZeP85x8__zpdvOl2t5cf9183FbIGRsrFNK3soWGWtsBA8qcdq3VHWplmWS2dULqVgklBaccLVXAtfTeKtEJi-ycfFh8d1M7uA5dHLPtzS6Hwea9STaY55sYfpi79NOwWkrasNng3aNBTg-TK6MZQkHX9za6NBWjgVGuuNAzuV5IzKmU7PzxCwVzqNMgHmQN5k-d88Hbv7Md8af-ZqBagPlZ50obUsHgIrojup02m8Vy1_mZh__wcwKbx4C9O2bQy0mIPuXB_kq578xo933KPtuIoRj2j_y_Ac-5pR4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>903148459</pqid></control><display><type>article</type><title>mTOR in podocyte function: Is rapamycin good for diabetic nephropathy?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Lu, Min-Kan ; Gong, Xing-Guo ; Guan, Kun-Liang</creator><creatorcontrib>Lu, Min-Kan ; Gong, Xing-Guo ; Guan, Kun-Liang</creatorcontrib><description>Comment on: Inoki K, et al. J Clin Invest 2011; 121:2181-2196 and Gödel M, et al. J Clin Invest 2011; 121:2197-2209</description><identifier>ISSN: 1538-4101</identifier><identifier>EISSN: 1551-4005</identifier><identifier>DOI: 10.4161/cc.10.20.17686</identifier><identifier>PMID: 22067710</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Animals ; Binding ; Biology ; Bioscience ; Calcium ; Cancer ; Cell ; Cycle ; Diabetic Nephropathies - drug therapy ; Diabetic Nephropathies - metabolism ; Landes ; Mechanistic Target of Rapamycin Complex 1 ; Mice ; Mice, Knockout ; Monomeric GTP-Binding Proteins - metabolism ; Multiprotein Complexes ; Neuropeptides - metabolism ; Organogenesis ; Podocytes - metabolism ; Podocytes - physiology ; Proteins ; Proteins - antagonists &amp; inhibitors ; Proteins - metabolism ; Ras Homolog Enriched in Brain Protein ; Signal Transduction - physiology ; Sirolimus - pharmacology ; Sirolimus - therapeutic use ; TOR Serine-Threonine Kinases - metabolism ; Tuberous Sclerosis Complex 1 Protein ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism</subject><ispartof>Cell cycle (Georgetown, Tex.), 2011-10, Vol.10 (20), p.3415-3416</ispartof><rights>Copyright © 2011 Landes Bioscience 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c433t-c56fb6b071aad03013e9eba9dc98a363abe569b85865414ca180496ffa85d5ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266173/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266173/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22067710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Min-Kan</creatorcontrib><creatorcontrib>Gong, Xing-Guo</creatorcontrib><creatorcontrib>Guan, Kun-Liang</creatorcontrib><title>mTOR in podocyte function: Is rapamycin good for diabetic nephropathy?</title><title>Cell cycle (Georgetown, Tex.)</title><addtitle>Cell Cycle</addtitle><description>Comment on: Inoki K, et al. J Clin Invest 2011; 121:2181-2196 and Gödel M, et al. J Clin Invest 2011; 121:2197-2209</description><subject>Animals</subject><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>Cycle</subject><subject>Diabetic Nephropathies - drug therapy</subject><subject>Diabetic Nephropathies - metabolism</subject><subject>Landes</subject><subject>Mechanistic Target of Rapamycin Complex 1</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Monomeric GTP-Binding Proteins - metabolism</subject><subject>Multiprotein Complexes</subject><subject>Neuropeptides - metabolism</subject><subject>Organogenesis</subject><subject>Podocytes - metabolism</subject><subject>Podocytes - physiology</subject><subject>Proteins</subject><subject>Proteins - antagonists &amp; inhibitors</subject><subject>Proteins - metabolism</subject><subject>Ras Homolog Enriched in Brain Protein</subject><subject>Signal Transduction - physiology</subject><subject>Sirolimus - pharmacology</subject><subject>Sirolimus - therapeutic use</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Tuberous Sclerosis Complex 1 Protein</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><issn>1538-4101</issn><issn>1551-4005</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM2LFDEQxYMo7udV2IvMzVOPlc5HJxdBBl2FgQVZzyFdnaxZupPZpFuZ_94ee3dwD-KpHtSvXj0eIW8orDmV9D3iepY1rGkjlXxBTqkQtOIA4uVBM1VxCvSEnJVyD1CrRtPX5KSuQTYNhVNyNdzefFuFuNqlLuF-dCs_RRxDihfklbd9cZeP85x8__zpdvOl2t5cf9183FbIGRsrFNK3soWGWtsBA8qcdq3VHWplmWS2dULqVgklBaccLVXAtfTeKtEJi-ycfFh8d1M7uA5dHLPtzS6Hwea9STaY55sYfpi79NOwWkrasNng3aNBTg-TK6MZQkHX9za6NBWjgVGuuNAzuV5IzKmU7PzxCwVzqNMgHmQN5k-d88Hbv7Md8af-ZqBagPlZ50obUsHgIrojup02m8Vy1_mZh__wcwKbx4C9O2bQy0mIPuXB_kq578xo933KPtuIoRj2j_y_Ac-5pR4</recordid><startdate>20111015</startdate><enddate>20111015</enddate><creator>Lu, Min-Kan</creator><creator>Gong, Xing-Guo</creator><creator>Guan, Kun-Liang</creator><general>Taylor &amp; Francis</general><general>Landes Bioscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20111015</creationdate><title>mTOR in podocyte function</title><author>Lu, Min-Kan ; Gong, Xing-Guo ; Guan, Kun-Liang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-c56fb6b071aad03013e9eba9dc98a363abe569b85865414ca180496ffa85d5ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>Cycle</topic><topic>Diabetic Nephropathies - drug therapy</topic><topic>Diabetic Nephropathies - metabolism</topic><topic>Landes</topic><topic>Mechanistic Target of Rapamycin Complex 1</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Monomeric GTP-Binding Proteins - metabolism</topic><topic>Multiprotein Complexes</topic><topic>Neuropeptides - metabolism</topic><topic>Organogenesis</topic><topic>Podocytes - metabolism</topic><topic>Podocytes - physiology</topic><topic>Proteins</topic><topic>Proteins - antagonists &amp; inhibitors</topic><topic>Proteins - metabolism</topic><topic>Ras Homolog Enriched in Brain Protein</topic><topic>Signal Transduction - physiology</topic><topic>Sirolimus - pharmacology</topic><topic>Sirolimus - therapeutic use</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Tuberous Sclerosis Complex 1 Protein</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Min-Kan</creatorcontrib><creatorcontrib>Gong, Xing-Guo</creatorcontrib><creatorcontrib>Guan, Kun-Liang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell cycle (Georgetown, Tex.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Min-Kan</au><au>Gong, Xing-Guo</au><au>Guan, Kun-Liang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>mTOR in podocyte function: Is rapamycin good for diabetic nephropathy?</atitle><jtitle>Cell cycle (Georgetown, Tex.)</jtitle><addtitle>Cell Cycle</addtitle><date>2011-10-15</date><risdate>2011</risdate><volume>10</volume><issue>20</issue><spage>3415</spage><epage>3416</epage><pages>3415-3416</pages><issn>1538-4101</issn><eissn>1551-4005</eissn><abstract>Comment on: Inoki K, et al. J Clin Invest 2011; 121:2181-2196 and Gödel M, et al. J Clin Invest 2011; 121:2197-2209</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>22067710</pmid><doi>10.4161/cc.10.20.17686</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-4101
ispartof Cell cycle (Georgetown, Tex.), 2011-10, Vol.10 (20), p.3415-3416
issn 1538-4101
1551-4005
language eng
recordid cdi_proquest_miscellaneous_903148459
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Animals
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
Diabetic Nephropathies - drug therapy
Diabetic Nephropathies - metabolism
Landes
Mechanistic Target of Rapamycin Complex 1
Mice
Mice, Knockout
Monomeric GTP-Binding Proteins - metabolism
Multiprotein Complexes
Neuropeptides - metabolism
Organogenesis
Podocytes - metabolism
Podocytes - physiology
Proteins
Proteins - antagonists & inhibitors
Proteins - metabolism
Ras Homolog Enriched in Brain Protein
Signal Transduction - physiology
Sirolimus - pharmacology
Sirolimus - therapeutic use
TOR Serine-Threonine Kinases - metabolism
Tuberous Sclerosis Complex 1 Protein
Tumor Suppressor Proteins - genetics
Tumor Suppressor Proteins - metabolism
title mTOR in podocyte function: Is rapamycin good for diabetic nephropathy?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A10%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=mTOR%20in%20podocyte%20function:%20Is%20rapamycin%20good%20for%20diabetic%20nephropathy?&rft.jtitle=Cell%20cycle%20(Georgetown,%20Tex.)&rft.au=Lu,%20Min-Kan&rft.date=2011-10-15&rft.volume=10&rft.issue=20&rft.spage=3415&rft.epage=3416&rft.pages=3415-3416&rft.issn=1538-4101&rft.eissn=1551-4005&rft_id=info:doi/10.4161/cc.10.20.17686&rft_dat=%3Cproquest_pubme%3E903148459%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=903148459&rft_id=info:pmid/22067710&rfr_iscdi=true